SREBF1 and atherosclerosis: In this study, we showed that orally administered RS significantly reduced the increased TCHO and TG levels in the blood of HFD-fed ApoE−/− mice and suppressed Srebp1 mRNA expression in arterial vessels, indicating that RS suppresses cholesterol production in the liver and blood vessels, thereby lowering blood LDL levels and reducing atherosclerosis.